Dexamethasone or prednisolone for asthma exacerbations in children: A cost‐effectiveness analysis
- 11 May 2020
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (7) , 1617-1623
Abstract
Objectives: Although a short course (ie, 3 to 5 days) of orally administered prednisolone is a common and widely accepted practice among clinicians for administering systemic corticosteroids in pediatric acute asthma, oral dexamethasone for 1 to 2 days is an attractive alternative to prednisolone due to its better palatability and compliance. However, a cost‐effectiveness analysis regarding the use of dexamethasone compared to prednisolone is not sufficient, especially in lower‐ and middle‐income countries. The objective of this study was to analyze the cost‐effectiveness of prednisolone vs oral dexamethasone for treating pediatric asthma exacerbations.Methods: Using a decision‐analysis model, we analyzed the cost‐effectiveness of prednisolone vs oral dexamethasone for treating acute pediatric asthma. Effectiveness parameters were derived from a systematic review of the published literature. Data for costs were acquired from hospital accounts and from an official national database, the national manual of drug prices in Colombia. The study was carried out from a Colombian third‐party payer perspective. The principal outcome of the model was the avoidance of hospitalization.Results: The base‐case analysis showed that compared to dexamethasone, administering prednisolone was associated with lower overall treatment costs (US$93.97 vs US$104.91 mean cost per patient) without a significant difference in the probability of hospitalization avoided (.9108 vs .9108).Conclusions: The present study shows that in Colombia, a middle‐income country, compared with oral dexamethasone, the use of prednisolone for treating acute pediatric asthma is cost‐effective, yielding a similar probability of hospitalization at lesser overall costs.Keywords
This publication has 18 references indexed in Scilit:
- Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trialTrials, 2012
- A Cost‐effectiveness Analysis of Dexamethasone Versus Prednisone in Pediatric Acute Asthma ExacerbationsAcademic Emergency Medicine, 2012
- A Comparison of Oral Dexamethasone With Oral Prednisone in Pediatric Asthma Exacerbations Treated in the Emergency DepartmentClinical Pediatrics, 2008
- Randomized Trial of Single-Dose Intramuscular Dexamethasone Compared With Prednisolone for Children With Acute AsthmaPediatric Emergency Care, 2007
- Single-Dose Oral Dexamethasone in the Emergency Management of Children With Exacerbations of Mild to Moderate AsthmaPediatric Emergency Care, 2006
- Adherence of Pediatric Asthma Patients With Oral Corticosteroid Prescriptions Following Pediatric Emergency Department Visit or HospitalizationPediatric Emergency Care, 2004
- Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthmaThe Journal of Pediatrics, 2001
- Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency departmentThe Journal of Pediatrics, 2001
- A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young childrenThe Journal of Pediatrics, 2000
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994